Formulation:
Each uncoated tablet contains:
- Pimobendan Ph.Eur 1.25, 2.5, 5, 10 mg
Indication:
- For the management of the signs of mild, moderate, or sever congestive heart failure due to atrioventricular valvular insufficiency (AVVI) or dilated cardiomyopathy (DCM).
Dosage and administration:
- The dose rate of Pimobendan is 0.5mg/kg body weight.
- The dose should be 0.25mg/kg body weight twice daily, one half of the dose in the morning and the other half approximately 12 hours later. Each dose should be given on an empty stomach and atleast one hour before feeding.
Commercial presentation:
- 3 x 10’s Tablets
